Company Directory - Regulus Therapeutics Inc.
Company Details - Regulus Therapeutics Inc.
Regulus Therapeutics Inc.
WebsiteSan Diego, United States
Regulus Therapeutics Inc. is a biotechnology company that focuses on developing innovative RNA-targeted therapeutics, which target the underlying causes of diseases using RNA modulation.
CCI Score
CCI Score: Regulus Therapeutics Inc.
0.00
Latest Event
Take Action
So what can you do? Support Regulus by shopping, spreading the word, or offering your support.
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
PENDING
Regulus Therapeutics Inc. is currently rated as a Pending.
Not yet scored CCI Score
The CCI rating for this company is not yet available.
Alternatives
USA
0.00
Corporation
3.96
Kenilworth, United States
2.79
Somerset, United States
1.17
San Diego, United States
-29.93
New Haven, USA
-38.38
Corporation
35.01
Corporation
19.24
Corporation
2.29
Corporation
1.53
Corporate Financials
- Revenue
- 2025
- $11.50M
- Total Assets
- 2025
- $92.00M
- Operating Income
- 2025
- -$25.00M
- Total Equity
- 2025
- $46.00M
Employees: 40
Industries
- 325414
- Biological Product (except Diagnostic) Manufacturing
- 541712
- Research and Development in the Physical, Engineering, and Life Sciences (Biotechnology)
- 541711
- Research and Development in Biotechnology